• Publications
  • Influence
The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials
TLDR
The Cochrane Collaboration’s tool for assessing risk of bias aims to make the process clearer and more accurate.
CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials
TLDR
This update of the CONSORT statement improves the wording and clarity of the previous checklist and incorporates recommendations related to topics that have only recently received recognition, such as selective outcome reporting bias.
CONSORT 2010 Statement: Updated Guidelines for Reporting Parallel Group Randomised Trials
TLDR
The 2010 version of the CONSORT Statement is described, which updates the previous reporting guideline based on new methodological evidence and accumulated experience.
The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration
TLDR
The CONSORT statement (or simply CONSORT) comprises a checklist of essential items that should be included in reports of RCTs and a diagram for documenting the flow of participants through a trial, aimed at first reports of two-group parallel designs.
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials
TLDR
The latest version of the CONSORT statement, CONSORT 2010, is described, which updates the reporting guideline based on new methodological evidence and accumulating experience.
Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials.
TLDR
Empirical evidence is provided that inadequate methodological approaches in controlled trials, particularly those representing poor allocation concealment, are associated with bias.
Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration.
TLDR
This elaboration and explanation document is developed from a review of the literature to provide examples of adequate reporting in trials of nonpharmacologic treatments and should help to improve the reporting of RCTs performed in this field.
The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials
TLDR
The revised CONSORT statement is intended to improve the reporting of an RCT, enabling readers to understand a trial's conduct and to assess the validity of its results.
The CONSORT statement: revised recommendations for improving the quality of reports of parallel group randomized trials
TLDR
The revised CONSORT statement is intended to improve the reporting of an RCT, enabling readers to understand a trial's conduct and to assess the validity of its results.
...
...